Saleem Elmasri - Nov 8, 2024 Form 3 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Role
CFO and Secretary
Signature
/s/ Saleem Elmasri
Stock symbol
JUNS
Transactions as of
Nov 8, 2024
Transactions value $
$0
Form type
3
Date filed
11/8/2024, 09:53 PM
Previous filing
Sep 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JUNS Stock option (right to buy) Nov 8, 2024 Common Stock 563K $1.33 Direct F1
holding JUNS Stock option (right to buy) Nov 8, 2024 Common Stock 81.6K $1.33 Direct F2
holding JUNS Stock option (right to buy) Nov 8, 2024 Common Stock 22.3K $1.33 Direct F3
holding JUNS Restricted stock unit Nov 8, 2024 Common Stock 66.3K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested stock options which were granted on January 1, 2023 pursuant to the approval of the board of directors of the issuer.
F2 Fully vested stock options which were granted on September 29, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F3 Fully vested stock options which were granted on December 18, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F4 Restricted stock units which were granted on December 18, 2023 under the Company's 2023 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock units vest at 100% 180 days after the first day of trading of an IPO.